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VENTILATOR-ASSOCIATED PNEUMONIA IN A
MULTI-HOSPITAL SYSTEM: DIFFERENCES IN
MICROBIOLOGY BY LOCATION
Hilary M. Babcock, MD; Jeanne E. Zack, BSN; Teresa Garrison, MSN; Ellen Trovillion, BSN; Marin H. Kollef, MD;
Victoria J. Fraser, MD

ABSTRACT
OBJECTIVE: To determine whether there were differences in the microbiologic etiologies of ventilator-associated
pneumonia in different clinical settings.
DESIGN: Observational retrospective cohort study of
microbiologic etiologies of ventilator-associated pneumonia from
1998 to 2001 in a multi-hospital system. Microbiologic results
were compared between hospitals and between different intensive care units (ICUs) within hospitals.
SETTING: Three hospitals—one pediatric teaching hospital, one adult teaching hospital, and one community hospital—
in one healthcare system in the midwestern United States.
PATIENTS: Patients at the target hospitals who developed ventilator-associated pneumonia and for whom microbiologic data were available.
RESULTS: Seven hundred fifty-three episodes of ventila-

Ventilator-associated pneumonia is a common hospital-acquired infection among patients requiring mechanical ventilation, resulting in excess mortality, prolonged
hospitalization, and increased costs of medical care.1-5 The
estimated rate of ventilator-associated pneumonia ranges
from 10% to 65% and reported mortality rates are high.3-8
The increase in mortality has been found in several studies to be independent of severity of illness and underlying
diagnoses. An episode of ventilator-associated pneumonia
can also increase the length of hospital stay by 6 to more
than 30 days and add at least $5,000 to the cost of the hospitalization.5,7
Recently, the importance of adequate empiric
antimicrobial therapy for nosocomial infections has been
emphasized. Inadequate antibiotic therapy has been associated with increased mortality from ventilator-associated
pneumonia in several studies.7,9-14 Risk factors for receiving inadequate antimicrobial therapy include prior antibiotic exposure, presence of invasive devices, prolonged
hospital stay, and prolonged ventilatory support.14 Several
studies have recommended that antibiotic choices be guid-

tor-associated pneumonia had culture data available for review.
The most common organisms at all hospitals were Staphylococcus
aureus (28.4%) and Pseudomonas aeruginosa (25.2%). The pediatric hospital had higher proportions of Escherichia coli (9.5% vs
2.3%; P < .001) and Klebsiella pneumoniae (13% vs 3.1%; P < .001)
than did the adult hospitals. In the pediatric hospital, the pediatric ICU had higher P. aeruginosa rates than did the neonatal
ICU (33.3% vs 17%; P = .01). In the adult hospitals, the surgical
ICU had higher Acinetobacter baumannii rates (10.2% vs. 1.7%;
P < .001) than did the other ICUs.
CONCLUSIONS: Microbiologic etiologies of ventilatorassociated pneumonia var y between and within hospitals.
Knowledge of these differences can improve selection of initial
antimicrobial regimens, which may decrease mortality (Infect
Control Hosp Epidemiol 2003;24:853-858).

ed by knowledge of the common etiologic agents for ventilator-associated pneumonia in individual hospitals.13-16
There may be significant differences in the microbiologic etiologies of pneumonia in different hospitals and
in different intensive care units (ICUs) within a single
hospital. Little data exist about ventilator-associated pneumonia in pediatric settings. We reviewed cases of ventilator-associated pneumonia from 1998 to 2001 from three
different hospitals (an urban teaching center, a suburban
community hospital, and a pediatric teaching facility) in a
single healthcare system to evaluate differences in common microbiologic etiologies of ventilator-associated
pneumonia among different types of hospitals and among
different locations within each hospital.
METHODS

Setting
This study was performed using data from three
hospitals—one teaching, one community, and one pediatric—within Barnes–Jewish Christian (BJC) HealthCare,
a 13-hospital integrated healthcare delivery system in
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ADULTS17

Pneumonia must meet only one of the following three criteria groups but may meet more:
A. Group 1: Patient has rales or dullness to percussion on physical examination of the chest AND at least one of the following:
a. New onset of purulent sputum or change in character of sputum.
b. Organism isolated from blood culture.
c. Isolation of pathogen from a specimen obtained by BAL, transtracheal aspirate, bronchial brushing, or biopsy.
B. Group 2: Patient has a chest radiographic examination that shows new or progressive infiltrate, consolidation, cavitation, or pleural effusion
that persists for greater than 48 hours AND at least one of the following:
a. New onset of purulent sputum or change in character of sputum.
b. Organism isolated from blood culture.
c. Isolation of pathogen from a specimen obtained by BAL, transtracheal aspirate, bronchial brushing, or biopsy.
d. Isolation of virus or detection of viral antigen in respiratory secretions.
e. Diagnostic single antibody titer (IgM) or fourfold increase in paired sera (IgG) for pathogen.
f. Histopathologic evidence of pneumonia.
C. Group 3: Patient has a chest radiographic examination that shows new or progressive infiltrate, consolidation, cavitation, or pleural effusion
that persists for greater than 48 hours AND the following two criteria:
a. Fever above 38.3°C.
b. White blood cells greater than 10,000/mm3.
BAL = bronchoalveolar lavage.

eastern Missouri and western Illinois, which is affiliated
with Washington University School of Medicine. The
teaching hospital, an urban university-affiliated hospital,
is a 1,000-bed primary-care and tertiary-care facility. An
average of 6,400 patients are admitted annually to the six
ICUs (medical, 19 beds; surgical–trauma–burns, 18 beds;
cardiac care, 18 beds; medical–surgical, 12 beds; surgical
cardiothoracic, 17 beds; and neurologic–neurosurgical, 20
beds).
The community hospital is a 500-bed private community hospital serving suburban St. Louis, Missouri, and the
surrounding rural communities of eastern Missouri. This
hospital has two 10-bed combined medical and surgical
ICUs, which admit approximately 140 patients, combined,
per month. There is also a 10-bed cardiothoracic ICU.
The pediatric hospital is a 235-bed academic tertiary-care center affiliated with Washington University
School of Medicine. It has a 300-mile radius referral base
in southeastern Missouri and southwestern Illinois. The
pediatric hospital has two ICUs: a pediatric ICU (PICU)
and a neonatal ICU (NICU). It is a level III NICU with 700
to 750 admissions per year with an average census of 50
patients and a 52-bed capacity. It is a combined medical–surgical PICU with 26 beds. The PICU admits
approximately 1,400 patients annually.
Study Methods
The data analyzed for this study were obtained from
the Infection Control and Hospital Epidemiology database
of BJC HealthCare to evaluate the a priori hypothesis that
differences in microbiologic etiologies of ventilatorassociated pneumonia exist within and between hospitals.
In each of the study hospitals, ventilator-associated pneu-

monia is a targeted nosocomial infection monitored
through prospective surveillance by infection control specialists.
The infection control specialists at these three facilities are all registered nurses, and all have completed
infection control certification through the Association for
Professionals in Infection Control and Epidemiology, Inc.
All of the BJC HealthCare hospitals participate in a coordinated Infection Control and Hospital Epidemiology
Consortium, which facilitates monthly meetings of the
specialists from all of the system’s hospitals. Definitions
and processes for surveillance are agreed on at the
Consortium level, and all specialists are trained in the use
of the definitions for surveillance. The definitions of ventilator-associated pneumonia used for surveillance are
based on the Centers for Disease Control and Prevention
National Nosocomial Infections Surveillance System definitions17 and are listed in Table 1 (adults) and Table 2
(children).
Each case of pneumonia identified by the specialists is reported, on paper or electronically, to the
Consortium, where the reports from all of the hospitals
are compiled into the Infection Control and Hospital
Epidemiology database. The date that the patient meets
the above criteria is recorded as the date of onset. Other
information collected for each case includes date of intubation, date of admission, hospital and ICU location, and
culture results. Demographic data were not uniformly
collected. Episodes of ventilator-associated pneumonia
from 1998 to 2001 from the three hospitals described
above were reviewed to determine their microbiologic
etiologies.
We reviewed all reported episodes of ventilator-
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1. Patient younger than 12 months has two of the following: apnea, tachypnea, bradycardia, wheezing, rhonchi, or cough AND any of the following:
a. Increased production of respiratory secretions.
b. New onset of purulent sputum or change in character of sputum.
c. Organism is isolated from blood culture.
d. Isolation of pathogen from specimen obtained by transtracheal aspirate, bronchial brushing, or biopsy.
e. Isolation of virus or detection of viral antigen in respiratory secretions.
f. Diagnostic single antibody titer (IgM) or fourfold increase in paired serum samples (IgG) for pathogen.
g. Histopathologic evidence of pneumonia.
2. Patient older than 12 months has chest radiologic examination that shows new or progressive infiltrate, cavitation, consolidation, or pleural
effusion AND any of the following:
a. Increased production of respiratory secretions.
b. New onset of purulent sputum or change in character of sputum.
c. Organism isolated from blood culture.
d. Isolation of pathogen from specimen obtained by transtracheal aspirate, bronchial brushing, or biopsy.
e. Isolation of virus or detection of viral antigen in respiratory secretions.
f. Diagnostic single antibody titer (IgM) or fourfold increase in paired serum samples (IgG) for pathogen.
g. Histopathologic evidence of pneumonia.

associated pneumonia for which any respiratory cultures
dated from 7 days before to 7 days after the date of diagnosis were recorded by the infection control specialist.
Most (82.5%) of the recorded cultures were performed
within 2 days of the date of the diagnosis of pneumonia.
Episodes for which negative cultures were recorded were
included. Cases were excluded if no culture data were
included in the pneumonia report by the infection control
specialist. Only first episodes of ventilator-associated
pneumonia were included in the analysis to ensure the
independence of observations. Duplicate culture reports
and multiple cultures with the same results from one
episode of ventilator-associated pneumonia were
removed. Culture results reported as “no growth” or “normal flora” were categorized as “no causative organism
identified.” Cases of ventilator-associated pneumonia
were categorized as early, occurring within the first 4 days
on the ventilator, and late, occurring after 5 or more days
on the ventilator.18-21 Data were summarized for all three
hospitals combined and then compared between adult and
pediatric hospitals, between teaching and community
adult hospitals, and between types of ICUs at all three
hospitals.
Statistical Methods
Data were analyzed using SPSS software (version
10.0; SPSS, Inc., Chicago, IL). Comparisons were made
using the chi-square or, when appropriate, Fisher’s exact
test. All tests of significance were two-tailed with a P value
of less than .05 considered significant. Adjustment for
multiple comparisons was made with the Bonferroni correction. Human Subjects Committee approval was
obtained for this study from the Washington University
Human Subjects Committee.

RESULTS

In the three hospitals, there were 931 episodes of
ventilator-associated pneumonia among 878 patients.
Most patients had one episode of ventilator-associated
pneumonia (834; 94.9%); 44 patients had more than one
episode (second episodes were excluded from the analysis). One hundred fifty-eight (16.9%) of the episodes were
early ventilator-associated pneumonia (occurring within
96 hours of intubation). The proportion of early ventilatorassociated pneumonia was lower at the pediatric hospital
(11.4% vs 19.7%; P = .0068). Microbiologic data were
included in the pneumonia report for 795 episodes. For
the purposes of analysis, only first episodes of pneumonia
among patients were included, leaving 753 episodes of
ventilator-associated pneumonia: 200 at the pediatric hospital, 130 at the community hospital, and 423 at the teaching hospital. Only one organism was identified in most of
the episodes of ventilator-associated pneumonia (589;
78.2%). Two organisms were identified in 126 (16.7%) of
the episodes and 38 (5%) of the episodes had more than
two organisms identified. In 128 (17%) of the cases of ventilator-associated pneumonia, no causative organism was
identified (Table 3). Cases with no identified causative
organism were more common in the adult hospitals (123
of 128; 96.1%).
In the three hospitals combined, Staphylococcus
aureus was the most commonly isolated organism associated with ventilator-associated pneumonia (isolated 214
times in 753 episodes; 28.4%). Of those isolates, 78 (36.4%)
were resistant to methicillin. Pseudomonas aeruginosa was
the second most commonly identified organism (190;
25.2%). Several different gram-negative rods were found
in approximately 6% of the cases (Table 3). The distribution of organisms at the three hospitals is shown in Figure
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AT THE

No. of Infections
%)
Associated With Organism (%
Early VAP*
Late VAP*
(n = 137)
(n = 616)
Total

Pseudomonas aeruginosa
22 (16)
Methicillin-sensitive
30 (21.9)
Staphylococcus aureus
Methicillin-resistant
11 (8)
Staphylococcus aureus
Enterobacter cloacae
4 (2.9)
Acinetobacter baumannii
4 (2.9)
Klebsiella pneumoniae
3 (2.2)
Serratia marcescens
6 (4.4)
Stenotrophomonas maltophilia 5 (3.6)

168 (27.3)
106 (17.2)

190 (25.2)
136 (18.1)

67 (10.9)

78 (10.3)

43 (7)
40 (6.5)
40 (6.5)
30 (4.9)
27 (4.4)

47 (6.2)
44 (5.8)
43 (5.7)
36 (4.7)
32 (4.2)

VAP = ventilator-associated pneumonia.
*Early VAP = within 4 days of intubation; late VAP = after 5 or more days of mechanical ventilation.

1. In the adult hospitals, the proportion of infections with
P. aeruginosa was higher in late cases of ventilator-associated pneumonia (28.8% vs 14.8%; P = .002) and the proportion of infections with Haemophilus influenzae was higher
in early cases of ventilator-associated pneumonia (6% vs
0.7%; P = .001). In the pediatric hospital, there were no significant differences in etiologies between early and late
infections.
The most common organisms associated with ventilator-associated pneumonia were similar at the adult and
the pediatric hospitals (Table 4). Staphylococcus aureus
and P. aeruginosa were the most frequently identified
pathogens in both settings. Rates of methicillin resistance
were higher at the adult hospitals (44.6% vs 14%; P < .001).
In the pediatric setting, the proportion of infections with
Escherichia coli, Enterobacter cloacae, and Klebsiella was
higher (Table 4).
Within the pediatric hospital, the microbiology of
ventilator-associated pneumonia differed between the
PICU and the NICU. Staphylococcus aureus and P. aeruginosa were the most frequently identified pathogens in
both ICUs; however, P. aeruginosa was more common in
the PICU (33.3% vs 17%; P = .01) and Staphylococcus aureus
was more common in the NICU (38% vs 17.6%; P = .002)
(Fig. 2). Rates of methicillin resistance in Staphylococcus
aureus were slightly higher in the NICU (NICU, 6 of 38
[15.8%] vs PICU, 2 of 15 [13.3%]; P = not significant),
although the overall numbers were small. The NICU had
a higher proportion of pneumonias associated with
Escherichia coli (14% vs 3.6%; P = .015) and the PICU had
a higher proportion of pneumonias associated with H.
influenzae (8.3% vs 0%; P = .003).
There were fewer differences between the adult
teaching hospital and the adult community hospital.

FIGURE 1. Organisms isolated from patients with ventilator-associated
pneumonia by hospital. VAP = ventilator-associated pneumonia; MSSA =
methicillin-susceptible Staphylococcus aureus; MRSA = methicillin-resistant S. aureus. *Statistically significant after correction for multiple comparisons.

Again, the most common organisms were Staphylococcus
aureus and P. aeruginosa. The rate of methicillin resistance was higher at the community hospital than at the
teaching facility (78.1% vs 36%; P < .001). The proportion
of ventilator-associated pneumonia associated with
Enterobacter cloacae was higher at the community hospital (7.7% vs 0.9%; P < .001). The proportion of ventilatorassociated pneumonia with Escherichia coli was also higher at the community hospital (5.4% vs 1.4%; P = .009),
although this result was not significant after correction for
multiple comparisons.
Within the adult hospitals, differences were also
seen by location within the hospital. The community hospital has two medical–surgical ICUs and one
cardiothoracic ICU. The teaching hospital has six separate ICUs: medical, cardiac, surgical, cardiothoracic, neurologic–neurosurgical, and a combined medical–surgical
ICU. The most common organisms associated with ventilator-associated pneumonia in all of the adult ICUs were
Staphylococcus aureus and P. aeruginosa. Staphylococcus
aureus was the most commonly isolated organism in the
dedicated surgical ICU, in the neurologic–neurosurgical
ICU, and in the combined medical–surgical ICUs. The
highest level of Staphylococcus aureus isolation was in the
neurologic–neurosurgical ICU (38% vs 25.4% in other
units combined; P = .02), although the difference was not
statistically significant after correction for multiple comparisons. P. aeruginosa was the most commonly isolated
organism in the dedicated medical ICU, the dedicated cardiac care unit, and the cardiothoracic units. Acinetobacter
baumannii occurred with increased frequency in the dedicated surgical ICU (10.2% vs 1.7%; P < .001). H. influenzae
occurred with increased frequency in the cardiothoracic
ICUs (8% vs 1%; P = .005), as did Escherichia coli (8% vs
1.8%; P = .022), although that difference was not significant after correction for multiple comparisons.
DISCUSSION

Nosocomial infections are common causes of
excess morbidity and hospital costs among patients
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TABLE 4
MICROBIOLOGY OF VENTILATOR-ASSOCIATED PNEUMONIA
PEDIATRIC AND ADULT HOSPITALS

Organism
Identified
Staphylococcus aureus
Methicillin-resistant
Staphylococcus aureus
Pseudomonas aeruginosa
Escherichia coli
Enterobacter cloacae
Acinetobacter baumannii
Klebsiella pneumoniae
Klebsiella oxytoca
Serratia marcescens
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857

AT THE

No. of Cultures With
% of VAP)
Organism (%
Pediatric
Adult
Hospital
Hospitals
(n = 200 VAP) (n = 553 VAP)

P

57 (28.5)
8 of 57 (14)

157 (28.4)
.7151
70 of 157 (44.6) .0001*

47 (23.5)
19 (9.5)
33 (16.5)
16 (8)
26 (13)
7 (3.5)
13 (6.5)

143 (25.9)
13 (2.3)
14 (2.5)
28 (5.1)
17 (3.1)
3 (0.5)
23 (4.2)

.9462
.0001*
.0001*
.1291
.0001*
.0022*
.0225

VAP = ventilator-associated pneumonia.
*Statistically significant after Bonferroni correction for multiple comparisons.

requiring intensive care. We evaluated microbial etiologies of ventilator-associated pneumonia in three hospitals
in a single healthcare system. The organisms associated
with ventilator-associated pneumonia that we identified
are similar to those reported in the literature.12,13,15,16,18
The most common causes overall are P. aeruginosa and
Staphylococcus aureus. Early cases of ventilator-associated
pneumonia are more commonly associated with methicillin-sensitive Staphylococcus aureus and late cases with
methicillin-resistant Staphylococcus aureus.19 Although
there are fewer reports of causative organisms in the pediatric literature, our findings were similar to their findings,22,23 with aerobic gram-negative bacteria and
Staphylococcus aureus being the most commonly identified.
We identified significant differences among the
three different hospitals and the different ICUs within
each hospital. Methicillin resistance in Staphylococcus
aureus was more frequent at the adult hospitals than at
the pediatric hospital and, specifically, was higher at the
community hospital than at the teaching hospital. The
increased resistance among adults may be due to a higher rate of chronic illness and more extensive contact with
the healthcare system. The lower proportion at the teaching hospital may be attributable to more aggressive infection control efforts. The elevated level of resistance at the
community hospital may be due to several outbreaks of
methicillin-resistant Staphylococcus aureus in the ICUs
there. This amount of methicillin resistance at the community hospital is instructive, reinforcing that antibiotic
resistance is not limited to large urban teaching hospitals.
We also found significant differences between ICUs
within individual hospitals. Within the pediatric hospital,

FIGURE 2. Microbiology of ventilator-associated pneumonia at the pediatric hospital: pediatric intensive care unit (PICU) versus neonatal intensive
care unit (NICU). VAP = ventilator-associated pneumonia. *Statistically significant after correction for multiple comparisons.

methicillin-resistant Staphylococcus aureus rates were
higher in the NICU than in the PICU (Fig. 2). A. baumannii occurred with increased frequency in the adult surgical ICU and Staphylococcus aureus occurred with
increased frequency in the neurologic–neurosurgical
ICU.
There are few data available about microbial etiologies of ventilator-associated pneumonia in different settings. In 1999, Rello et al.24 found significant variation in
the etiologies of ventilator-associated pneumonia among
four different hospitals, three in Spain and one in France.
Their study used quantitative bronchoscopic techniques
for diagnosis and also included antibiotic use as a variable. However, their study was performed only in teaching facilities and only in adult hospitals. They suggested
the possibility that, in large hospitals, the etiology of ventilator-associated pneumonia may var y significantly
between ICUs, which we found to be true. Namias et al.15
found significant variability in antibiotic susceptibility
between ICUs in a large teaching hospital. However, their
study was confined to one hospital during a short (3month) time period. They recommended the use of ICUspecific antibiograms to improve empiric antibiotic selection.
The importance of making appropriate antibiotic
choices initially in the treatment of nosocomial infections
is being increasingly appreciated. We found the organisms frequently associated with inadequate antimicrobial
therapy in ventilator-associated pneumonia, specifically P.
aeruginosa, Staphylococcus aureus, and Acinetobacter
species,14 to be common and to fluctuate in frequency
between different hospitals and ICUs. Awareness of local
patterns of microbiologic etiologies of nosocomial infections can improve the selection of appropriate therapy.24-26
This information may also be helpful in developing targeted interventions to prevent contamination and infection.
This study has several limitations. This was a retrospective study, relying on data collected by infection con-
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trol specialists, although the specialists in this health system are highly trained. Patients who had multiple cultures
performed, if more than one organism was identified, will
be overrepresented in the database. However, these
results reflect the microbiologic data available to the treating physicians and their culturing practices. Although we
had a fairly large sample size, 753 episodes of ventilatorassociated pneumonia with culture data, the data came
from only three hospitals and may not be generalizable to
other institutions. Also, we did not collect information on
antibiotic use in each setting.
As increased attention is turned to the role of adequate initial antibiotic therapy in treating nosocomial
infections such as ventilator-associated pneumonia, the
importance of local microbiologic data in making antibiotic selections is being recognized. This article demonstrates that the expected pathogens that empiric regimens should cover may var y significantly between
individual hospitals and even between individual ICUs
within one hospital. Knowledge of these local differences
could improve selection of initial antimicrobial regimens
and may improve outcomes from nosocomial infections.
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